Participants Needed For Schizophrenia and Bipolar Illness Study
June 21, 2012
HOUSTON - The Michael E. DeBakey VA Medical Center (MEDVAMC) is currently conducting research addressing the genetics of functional disability of individuals suffering with schizophrenia and bipolar illness.
Schizophrenia and bipolar disorder are chronic psychiatric diseases associated with considerable lifelong disability. Both conditions are known to have major genetic aspects with possible additional genetic contributions to their course and how they affect patients’ daily lives.
“Genetic testing is a powerful tool to study any given disorder, including schizophrenia and bipolar disorder,” said Rayan Al Jurdi, M.D., a MEDVAMC psychiatrist and an associate professor at Baylor College of Medicine. “However, a great many large-scale studies in this area have been curtailed because of the lack of study participants or lack of diversity in the patients studied.”
The goal of the study is to conduct a gene-association analysis, comparing the DNA of 9,000 Veterans with schizophrenia and 9,000 Veterans with bipolar illness to the DNA of approximately 20,000 “mentally healthy” Veterans. This will help researchers discover genetic risk factors related to these disorders.
Researchers also hope to further define functional capacity among patients with schizophrenia and bipolar illness using tests previously shown to be connected to real-world functional disability and to establish a specimen and data repository for future research.
Treatments for schizophrenia and bipolar disorder have improved in the last few years, but are still associated with relatively high rates of side effects.
“Genetic studies can also help researchers develop better treatments,” said Al Jurdi. “This is extremely important because suicide attempts and completed suicides are very common in these two populations.”
Veterans who qualify and participate in the study will receive $60 compensation for their time and inconvenience.
# # #
Awarded re-designation for Magnet Recognition for Excellence in Nursing Services in 2008, the Michael E. DeBakey VA Medical Center serves as the primary health care provider for more than 130,000 Veterans in southeast Texas and provides some of the most complex care within the VA Health Care System. The DeBakey VA employs nearly 3,600 staff and is one of 49 institutions within the prestigious Texas Medical Center*, one of the largest health and research centers in the world. The DeBakey VA is home to a Post Traumatic Stress Disorder Clinic; Network Polytrauma Center; award-winning Cardiac and General Surgery Program; Liver Transplant Center; Epilepsy and Cancer Centers of Excellence; Substance Abuse Disorder Quality Enhancement Research Initiative; Health Services Research & Development Center of Excellence; Rehabilitation Research of Excellence focusing on mild to moderate traumatic brain injury; Mental Illness Research, Education and Clinical Center; $26.8 million Research and Development Program; and Parkinson’s Disease Research, Education, and Clinical Center. The hospital offers sophisticated, cutting-edge technology such as PET/CT imaging, the Evident™ microwave ablation system, a CyberKnife®, a Varian Trilogy linear accelerator, a Philips Wide Bore Computed Tomography Simulator, the OR•Control System, the Abiomed Impella 2.5 catheter-based heart pump, and the Sapien heart valve. For more than 60 years, the DeBakey VA has served as the primary teaching facility for our major affiliate, Baylor College of Medicine* and operates one of the largest VA residency programs in the nation. Each academic year, more than 2,179 students are trained through 194 affiliation agreements with institutions of higher learning. Including the outpatient clinics in Beaumont, Conroe, Galveston, Houston, Lufkin, Richmond, and Texas City, MEDVAMC outpatient clinics logged almost 1.3 million outpatient visits in fiscal year 2011.